Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.02 - ACUTE MANAGEMENT - Thrombolysis or thrombectomy P716 - ESOC25-2036 IMPACT OF ONSET MODE ON TENECTEPLASE FOR ISCHEMIC STROKE AT 4.5 TO 24 HOURS: A POST-HOC ANALYSIS OF THE TRACE-III TRIAL Zhixin Cao 1 , Jinfeng Yin 2 , Liyuan Wang 1 , Manjun Hao 1 , Shuangzhe Wu 1 , Yunyun Xiong 1,2 , Yongjun Wang 1,2 1 Beijing Tiantan Hospital, Capital Medical University, Beijing, China, 2 China National Clinical Research Center for Neurological Diseases, Beijing, China Background and Aims: Whether the efficacy and safety of tenecteplase is different in patients with wake-up and witnessed onset strokes remains uncertain
TRIUMPH-1, TRIUMPH-2, TRIUMPH-3, TRIUMPH-4, TRIUMPH-5 retatrutide clinical trial registrations
Retatrutide is an investigational triple incretin receptor agonist that simultaneously activates glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Life Skills Training Activities: Practical activities such as cooking simple recipes, managing money, using public transport, and operating home appliances are incorporated into OT for older children and adults to build real-world independence
